Clinical Trial Detail

NCT ID NCT03792256
Title Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group
Indications

lymphoblastic lymphoma

lymphoid leukemia

Therapies

Cytarabine + Hydrocortisone + Methotrexate

Cytarabine + Doxorubicin + Palbociclib + Pegaspargase + Prednisone + Vincristine Sulfate

Methotrexate

Cytarabine + Doxorubicin + Palbociclib + Pegaspargase + Prednisolone + Vincristine Sulfate

Age Groups: adult child

No variant requirements are available.